BME100 s2015:Group16 12pmL2: Difference between revisions
(4 intermediate revisions by 2 users not shown) | |||
Line 17: | Line 17: | ||
| [[Image: Hannamonroen.jpg|100px|thumb|Name: Hanna Monroe]] | | [[Image: Hannamonroen.jpg|100px|thumb|Name: Hanna Monroe]] | ||
| [[Image:BME103student.jpg|100px|thumb|Name: Natkanes Pakjirasirikul]] | | [[Image:BME103student.jpg|100px|thumb|Name: Natkanes Pakjirasirikul]] | ||
| [[Image: | | [[Image:reaghanfletcher.jpg|100px|thumb|Name: Reaghan Fletcher]] | ||
|} | |} | ||
Line 36: | Line 36: | ||
This was a rat based study to see if the LPS treatment increased Inflammotin protein levels | This was a rat based study to see if the LPS treatment increased Inflammotin protein levels | ||
[[Image:Rate_table.jpg]] | |||
<br><br> | <br><br> | ||
Line 52: | Line 54: | ||
'''Experiment 2''' <br> | '''Experiment 2''' <br> | ||
[[Image: | [[Image:RatGraph.jpg]] | ||
Line 75: | Line 77: | ||
==Summary/Discussion== | ==Summary/Discussion== | ||
Based on the p-value for experiment 1, there is a statistically significant difference among the different doses of LPS. Upon further analysis between all groups, each comparison showed significance when comparing the t-test values to the corrected p-value. In this study of inflammotin and the elderly, we found that the dose of LPS does make a difference in the amount of inflammotin in elderly. However, in experiment 2, there was no significant difference between the doses of LPS. The dose of LPS does not make a significant difference in the amount of inflammotin. |
Revision as of 13:59, 28 January 2015
BME 100 Spring 2015 | Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help | |||||
OUR TEAMLAB 2 WRITE-UPDescriptive StatisticsExperiment 1 This was a human based study to see if various doses of LPS (0 mg, 5 mg, 10 mg, and 15 mg) increase the levels of inflammotin in the elderly at a retirement center.
This was a rat based study to see if the LPS treatment increased Inflammotin protein levels
ResultsExperiment 1
Experiment 2
AnalysisExperiment 1
Summary/DiscussionBased on the p-value for experiment 1, there is a statistically significant difference among the different doses of LPS. Upon further analysis between all groups, each comparison showed significance when comparing the t-test values to the corrected p-value. In this study of inflammotin and the elderly, we found that the dose of LPS does make a difference in the amount of inflammotin in elderly. However, in experiment 2, there was no significant difference between the doses of LPS. The dose of LPS does not make a significant difference in the amount of inflammotin. |